Healthcare company-building profile
Lilly Gateway Labs
Eli Lilly and Company
IncubatorIncubatorNot publicly documentedActive
Source-based profile
Program at a Glance
- Program type
- Incubator
- Program category
- Incubator
- Organization
- Eli Lilly and Company
- Organization type
- Not publicly documented
- Location
- Multiple, Multiple
- Company stage served
- Early stage
- Cohort or participation model
- Rolling residency; flexible-term private and shared lab suites
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Fee-based residency; Lilly does not take rights to resident programs as a condition of tenancy
- Equity or fee model
- Fee based
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
- Founded
- 2019
Public description
About the program
Lilly Gateway Labs is Eli Lilly's network of life science incubators providing early-stage biotech companies with private and shared wet-lab space, equipment and operational support without Lilly taking rights to their programs. Sites operate in the San Francisco Bay Area, Boston/Cambridge, San Diego and Boston Seaport, with a Philadelphia site announced. Residents also gain access to Lilly scientists through the wider Catalyze360 program.
What the program publicly emphasizes
Focus areas and features
Biotech and therapeuticsWet-lab residencyDrug discoveryRegional life science ecosystems
- Category: Incubator
- Program structure: Rolling residency; flexible-term private and shared lab suites
- Published terms: Fee-based residency; Lilly does not take rights to resident programs as a condition of tenancy
Sources
External source links open in a new tab.